Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Sickle Cell Disease Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Calimmune Inc
Genethon SA
bluebird bio Inc
Bristol-Myers Squibb Co
Gilead Sciences Inc
Daiichi Sankyo Co Ltd
Annexin Pharmaceuticals AB
Bioverativ Inc
Angiocrine Bioscience Inc
Addmedica SAS
Acceleron Pharma Inc
Gamida Cell Ltd
Bio Products Laboratory Ltd
Editas Medicine Inc
CSL Ltd
Errant Gene Therapeutics LLC
Global Blood Therapeutics Inc
CRISPR Therapeutics
ArQule Inc
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others
Application:
Hospital
Clinic
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Sickle Cell Disease Drug Industry Overview
-
1.1.1 Sickle Cell Disease Drug Market Scope and Market Segments
-
1.1.2 Sickle Cell Disease Drug Industry Characteristics
-
1.1.3 Global and China Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Sickle Cell Disease Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Sickle Cell Disease Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 ARQ-092
-
1.2.2 BIVV-003
-
1.2.3 CAL-H
-
1.2.4 CTX-001
-
1.2.5 DRX-194
-
1.2.6 Others
-
1.3 Global Sickle Cell Disease Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Clinic
-
1.3.3 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Sickle Cell Disease Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Sickle Cell Disease Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Sickle Cell Disease Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Sickle Cell Disease Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Sickle Cell Disease Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Sickle Cell Disease Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Sickle Cell Disease Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Sickle Cell Disease Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Sickle Cell Disease Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Sickle Cell Disease Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Sickle Cell Disease Drug Industry PEST Analysis
-
2.3 Sickle Cell Disease Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Sickle Cell Disease Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Sickle Cell Disease Drug Industry
Chapter 3 Global and China Sickle Cell Disease Drug Market, by Manufacturer
-
3.1 Global and China Sickle Cell Disease Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Sickle Cell Disease Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Sickle Cell Disease Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Sickle Cell Disease Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Sickle Cell Disease Drug Market Top 3 Players
Chapter 4 Global and China Sickle Cell Disease Drug Market, by Type (2017-2028)
-
4.1 Sickle Cell Disease Drug Market Trend, by Type
-
4.2 Global Sickle Cell Disease Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Sickle Cell Disease Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Sickle Cell Disease Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Sickle Cell Disease Drug Price Trend, by Type (2017-2028)
-
4.3 China Sickle Cell Disease Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Sickle Cell Disease Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Sickle Cell Disease Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Sickle Cell Disease Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Sickle Cell Disease Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Sickle Cell Disease Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Sickle Cell Disease Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Sickle Cell Disease Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Sickle Cell Disease Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Sickle Cell Disease Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Sickle Cell Disease Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Sickle Cell Disease Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Sickle Cell Disease Drug Market Analysis
-
7.1 North America Sickle Cell Disease Drug Market, by Type
-
7.2 North America Sickle Cell Disease Drug Market, by Application
-
7.3 North America Sickle Cell Disease Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Sickle Cell Disease Drug Market Analysis
-
8.1 Europe Sickle Cell Disease Drug Market, by Type
-
8.2 Europe Sickle Cell Disease Drug Market, by Application
-
8.3 Europe Sickle Cell Disease Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Sickle Cell Disease Drug Market Analysis
-
9.1 APAC Sickle Cell Disease Drug Market, by Type
-
9.2 APAC Sickle Cell Disease Drug Market, by Application
-
9.3 APAC Sickle Cell Disease Drug Market Analysis and Forecast, by Country
-
9.3.1 China Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Sickle Cell Disease Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Sickle Cell Disease Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Sickle Cell Disease Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Sickle Cell Disease Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Sickle Cell Disease Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Sickle Cell Disease Drug Company Profiles
-
11.1 Calimmune Inc
-
11.1.1 Calimmune Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Calimmune Inc Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.1.3 Calimmune Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Genethon SA
-
11.2.1 Genethon SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Genethon SA Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.2.3 Genethon SA Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 bluebird bio Inc
-
11.3.1 bluebird bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 bluebird bio Inc Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.3.3 bluebird bio Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Bristol-Myers Squibb Co
-
11.4.1 Bristol-Myers Squibb Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Bristol-Myers Squibb Co Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.4.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Gilead Sciences Inc
-
11.5.1 Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Gilead Sciences Inc Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.5.3 Gilead Sciences Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Daiichi Sankyo Co Ltd
-
11.6.1 Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.6.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Annexin Pharmaceuticals AB
-
11.7.1 Annexin Pharmaceuticals AB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.7.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Bioverativ Inc
-
11.8.1 Bioverativ Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Bioverativ Inc Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.8.3 Bioverativ Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Angiocrine Bioscience Inc
-
11.9.1 Angiocrine Bioscience Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Angiocrine Bioscience Inc Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.9.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Addmedica SAS
-
11.10.1 Addmedica SAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Addmedica SAS Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.10.3 Addmedica SAS Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Acceleron Pharma Inc
-
11.11.1 Acceleron Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Acceleron Pharma Inc Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.11.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Gamida Cell Ltd
-
11.12.1 Gamida Cell Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Gamida Cell Ltd Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.12.3 Gamida Cell Ltd Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Bio Products Laboratory Ltd
-
11.13.1 Bio Products Laboratory Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Bio Products Laboratory Ltd Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.13.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Editas Medicine Inc
-
11.14.1 Editas Medicine Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Editas Medicine Inc Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.14.3 Editas Medicine Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 CSL Ltd
-
11.15.1 CSL Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 CSL Ltd Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.15.3 CSL Ltd Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Errant Gene Therapeutics LLC
-
11.16.1 Errant Gene Therapeutics LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.16.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Global Blood Therapeutics Inc
-
11.17.1 Global Blood Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Global Blood Therapeutics Inc Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.17.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 CRISPR Therapeutics
-
11.18.1 CRISPR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 CRISPR Therapeutics Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.18.3 CRISPR Therapeutics Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 ArQule Inc
-
11.19.1 ArQule Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 ArQule Inc Sickle Cell Disease Drug Product Profiles, Application and Specification
-
11.19.3 ArQule Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Sickle Cell Disease Drug Industry Investment Prospect and Risk Assessment
-
12.1 Sickle Cell Disease Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Sickle Cell Disease Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Sickle Cell Disease Drug Production Value and Growth Rate (2017-2028)
-
Figure China Sickle Cell Disease Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Sickle Cell Disease Drug Market Size and Growth Rate of ARQ-092 (2017-2028)
-
Figure Global Sickle Cell Disease Drug Market Size and Growth Rate of BIVV-003 (2017-2028)
-
Figure Global Sickle Cell Disease Drug Market Size and Growth Rate of CAL-H (2017-2028)
-
Figure Global Sickle Cell Disease Drug Market Size and Growth Rate of CTX-001 (2017-2028)
-
Figure Global Sickle Cell Disease Drug Market Size and Growth Rate of DRX-194 (2017-2028)
-
Figure Global Sickle Cell Disease Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Sickle Cell Disease Drug Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Sickle Cell Disease Drug Market Size and Growth Rate of Clinic (2017-2028)
-
Figure Global Sickle Cell Disease Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Sickle Cell Disease Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Sickle Cell Disease Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Sickle Cell Disease Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Sickle Cell Disease Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Sickle Cell Disease Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Sickle Cell Disease Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Sickle Cell Disease Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Sickle Cell Disease Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Sickle Cell Disease Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Sickle Cell Disease Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Sickle Cell Disease Drug Market Share, by Manufacturer in 2022
-
Table Global Sickle Cell Disease Drug Sales Volume, by Type (2017-2028)
-
Table Global Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Sickle Cell Disease Drug Sales Value, by Type (2017-2028)
-
Table Global Sickle Cell Disease Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Sickle Cell Disease Drug Price Trend, by Type (2017-2028)
-
Table China Sickle Cell Disease Drug Sales Volume, by Type (2017-2028)
-
Table China Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Table China Sickle Cell Disease Drug Sales Value, by Type (2017-2028)
-
Table China Sickle Cell Disease Drug Sales Value Share, by Type (2017-2028)
-
Figure China Sickle Cell Disease Drug Price Trend, by Type (2017-2028)
-
Table Global Sickle Cell Disease Drug Sales Volume, by Application (2017-2028)
-
Table Global Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Sickle Cell Disease Drug Sales Value, by Application (2017-2028)
-
Table Global Sickle Cell Disease Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Sickle Cell Disease Drug Sales Value Share, by Application (2017-2028)
-
Table China Sickle Cell Disease Drug Sales Volume, by Application (2017-2028)
-
Table China Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Table China Sickle Cell Disease Drug Sales Value, by Application (2017-2028)
-
Table China Sickle Cell Disease Drug Sales Value Share, by Application (2017-2028)
-
Figure China Sickle Cell Disease Drug Sales Value Share, by Application (2017-2028)
-
Figure China Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Sickle Cell Disease Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Sickle Cell Disease Drug Sales Volume, by Type (2017-2028)
-
Table North America Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Sickle Cell Disease Drug Sales Volume, by Application (2017-2028)
-
Table North America Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Sickle Cell Disease Drug Sales Volume, by Type (2017-2028)
-
Table Europe Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Sickle Cell Disease Drug Sales Volume, by Application (2017-2028)
-
Table Europe Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Sickle Cell Disease Drug Sales Volume, by Type (2017-2028)
-
Table APAC Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Sickle Cell Disease Drug Sales Volume, by Application (2017-2028)
-
Table APAC Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Sickle Cell Disease Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Sickle Cell Disease Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Sickle Cell Disease Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Sickle Cell Disease Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Sickle Cell Disease Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Sickle Cell Disease Drug Sales Value and Growth Rate (2017-2028)
-
Table Calimmune Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Calimmune Inc Product Profiles, Application and Specification
-
Table Calimmune Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genethon SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genethon SA Product Profiles, Application and Specification
-
Table Genethon SA Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table bluebird bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table bluebird bio Inc Product Profiles, Application and Specification
-
Table bluebird bio Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Co Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gilead Sciences Inc Product Profiles, Application and Specification
-
Table Gilead Sciences Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Daiichi Sankyo Co Ltd Product Profiles, Application and Specification
-
Table Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Annexin Pharmaceuticals AB Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Annexin Pharmaceuticals AB Product Profiles, Application and Specification
-
Table Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bioverativ Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bioverativ Inc Product Profiles, Application and Specification
-
Table Bioverativ Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Angiocrine Bioscience Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Angiocrine Bioscience Inc Product Profiles, Application and Specification
-
Table Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Addmedica SAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Addmedica SAS Product Profiles, Application and Specification
-
Table Addmedica SAS Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Acceleron Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Acceleron Pharma Inc Product Profiles, Application and Specification
-
Table Acceleron Pharma Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gamida Cell Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gamida Cell Ltd Product Profiles, Application and Specification
-
Table Gamida Cell Ltd Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bio Products Laboratory Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bio Products Laboratory Ltd Product Profiles, Application and Specification
-
Table Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Editas Medicine Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Editas Medicine Inc Product Profiles, Application and Specification
-
Table Editas Medicine Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CSL Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CSL Ltd Product Profiles, Application and Specification
-
Table CSL Ltd Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Errant Gene Therapeutics LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Errant Gene Therapeutics LLC Product Profiles, Application and Specification
-
Table Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Global Blood Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Global Blood Therapeutics Inc Product Profiles, Application and Specification
-
Table Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CRISPR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CRISPR Therapeutics Product Profiles, Application and Specification
-
Table CRISPR Therapeutics Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table ArQule Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ArQule Inc Product Profiles, Application and Specification
-
Table ArQule Inc Sickle Cell Disease Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
